Altered expression of cell cycle proteins and prolonged duration of cardiac myocyte hyperplasia in p27(KIP1) knockout mice

Circulation Research

Volumn 85, Issue 2, 1999, Pages 117-127

  Poolman, Robert A ^a   Li, Jian Mei ^a   Durand, Beatrice ^b   Brooks, Gavin ^a,c  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF READING   (United Kingdom)

Author keywords

Cardiac myocyte; Cell cycle; Hyperplasia; Mouse; p27(KIP1)

Indexed keywords

ALPHA ACTIN; ATRIAL NATRIURETIC FACTOR; BROXURIDINE; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; MESSENGER RNA; PROTEIN P21; PROTEIN P27;

ADOLESCENT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL HYPERPLASIA; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; HEART MUSCLE CELL; HEART SIZE; HEART WEIGHT; HYPERTROPHY; IMMUNOCYTOCHEMISTRY; KNOCKOUT MOUSE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033597955     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.85.2.117     Document Type: Article

References (56)

1. Claycomb WC. Control of cardiac muscle cell division. Trends Cardiovasc Med. 1992;2:231-236.
2. Li F, Wang X, Capasso JM, Gerdes AM. Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J Mol Cell Cardiol. 1996;28:1737-1746.
3. Soonpaa MH, Kim KK, Pajak L, Franklin M, Field LJ. Cardiomyocyte DNA synthesis and binucleation during murine development. Am J Physiol. 1996;271:H2183-H2189.
4. Capasso JM, Bruno S, Cheng W, Li P, Rodgers R, Darzynkiewicz Z, Anversa P. Ventricular loading is coupled with DNA synthesis in adult cardiac myocytes after acute and chronic myocardial infarction in rats. Circ Res. 1992;71:1379-1389.
5. McGill CJ, Brooks G. Cell cycle control mechanisms and their role in cardiac growth. Cardiovasc Res. 1995;30:557-569.
6. Brooks G, Poolman RA, Li J-M. Arresting developments in the cardiac myocyte cell cycle: role of cyclin-dependent kinase inhibitors. Cardiovasc Res. 1998;39:301-311.
7. Li J-M, Poolman RA, Brooks G. Role of G1 phase cyclins and cyclin-dependent kinases during cardiomyocyte hypertrophic growth in rats. Am J Physiol. 1998;275:H814-H822.
8. Poolman RA, Brooks G. CIP/KIP cyclin-dependent kinase inhibitor (CDKI) expression during cardiac myocyte development. J Mol Cell Cardiol. 1997;29:A19. Abstract.
9. KIP1 during myocyte development. Int J Cardiol. 1998; 67:133-142.
10. Brooks G, Poolman RA, McGill CJ, Li J-M. Expression and activities of cyclins and cyclin-dependent kinases in developing rat ventricular myocytes. J Mol Cell Cardiol. 1997;29:2261-2271.
11. McGill CJ, Poolman RA, Brooks G. Expression of cell cycle molecules during development of rat cardiac myocytes. J Mol Cell Cardiol. 1996; 28:A76. Abstract.
12. Tam SKC, Gu W, Mahdavi V, Nadal-Ginard B. Tumor suppressor genes and cell cycle regulators expression in cardiac development and hypertrophy. Circulation. 1993;88:I-240. Abstract.
13. Kang MJ, Kim I, Terhune A, Chae SW, Koh GY. The concurrent disappearance of mitotic cyclins and formation of binucleation in neonatal cardiomyocytes. Circulation. 1996;94:A2826. Abstract.
14. Kang MJ, Kim J-S, Chae S-W, Koh KN, Koh GY. Cyclins and cyclin dependent kinases during cardiac development. Mol Cell. 1997;7:360-366.
15. Sadoshima J, Aoki H, Izumo S. Angiotensin II and serum differentially regulate expression of cyclins, activity of cyclin-dependent kinases and phosphorylation of retinoblastoma gene product in neonatal cardiac myocytes. Circ Res. 1997;80:228-241.
16. Kang MJ, Koh GY. Differential and dramatic changes of cyclindependent kinase activities in cardiomyocytes during the neonatal period. J Mol Cell Cardiol. 1997;29:1767-1777.
17. Flink IL, Oana S, Maitra N, Bahl JJ, Morkin E. Changes in E2F complexes containing retinoblastoma protein family members and increased cyclin-dependent kinase inhibitor activities during terminal differentiation of cardiomyocytes. J Mol Cell Cardiol. 1998;30:563-578.
18. Poolman RA, Brooks G. Expression of CIP/KIP family of cyclin-dependent kinase inhibitors during cardiac development. Circulation. 1996;94:A0909. Abstract.
19. Burton PBJ, Yacoub MH, Barton PJR. Cell cycle regulatory molecule expression during heart development J Mol Cell Cardiol. 1997;29:A41. Abstract.
20. Horky M, Kuchtickova S, Vojtesek B, Kolar F. Induction of cell-cycle inhibitor p21 in rat ventricular myocytes during early postnatal transition from hyperplasia to hypertrophy. Physiol Res. 1997;46:233-235.
21. KIP1, in rat hearts during development. J Mol Cell Cardiol. 1998;30:463-474.
22. Li J-M, Brooks G. Down-regulation of the cyclin dependent kinase inhibitors, p21 and p27, in pressure overload hypertrophy. Am J Physiol. 1997;273:H1358-H1367.
23. Nakayama K, Ishida N, Shirane M, Inomata A, Inoue T, Shishido N, Horii I, Loh DY, Nakayama K-I. Mice lacking p27 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell. 1996;85:707-720.
24. Fero ML, Rivkin M, Tasch M, Porter P, Carrow CE, Firpo E, Polyak K, Tsai L-H, Broudy V, Perlmutter RM, Kaushansky K, Roberts JM. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27-deficient mice. Cell. 1996;85:733-744.
25. Kiyokawa H, Kineman RD, Manova-Tadorova KO, Soares VC, Hoffman ES, Ono M, Khanam D, Hayday AC, Frohman LA, Koff A. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27. Cell. 1996;85:721-732.
26. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell. 1995;82:675-684.
27. Durand B, Fero ML, Roberts JM, Raff MC. p27(Kip1) alters the response of cells to mitogens as part of a cell-intrinsic timer that arrests the cell cycle and initiates differentiation. Curr biol. 1998;8:431-440.
28. Poolman RA, Brooks G. Expressions and activities of cell cycle regulatory molecules during the transition from myocyte hyperplasia to hypertrophy. J Mol Cell Cardiol. 1998;30:2121-2135.
29. Toyoshima H, Hunter T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell. 1994;78:67-74.
30. Li JM, Horsfall AC, Maini RN. Anti-La (SS-B) but not anti-Ro52 (SS-A) antibodies cross-react with laminin: a role in the pathogenesis of congenital heart block? Clin Exp Immunol. 1995;99:316-324.
31. 3 in cardiomyocytes during pressure overload-induced hypertrophy. J Mol Cell Cardiol. 1997;29:2213-2224.
32. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
33. Pausson M, Saladin K. Mouse heart laminin. J Biol Chem. 1989;264: 18726-18732.
34. Chien KR, Knowlton KU, Zhu H, Chien S. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. FASEB J. 1991;5:3037-3045.
35. Christensen G, Wang Y, Chien KR. Physiological assessment of complex cardiac phenotypes in genetically engineered mice. Am J Physiol. 1997; 272:H2513-H2524.
36. Molkentin JD, Lu J-R, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, Olson EN. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell. 1998;93:215-228.
37. Poolman RA, Li J-M, Brooks G. Altered expression of cell cycle regulatory proteins in p27 knockout mice. Circulation. 1997;96(suppl 1):A30. Abstract.
38. Kip1. Genes Devel. 1997;11:2335-2346.
39. Kip1 safeguards against inflammatory injury. Nat Med. 1998;4:575-580.
40. Raff MC. Size control: the regulation of cell numbers in animal development. Cell. 1996;86:173-175.
41. Weigmann K, Cohen SM, Lehner CF. Cell cycle progression, growth and patterning in imaginal discs despite inhibition of cell division after inactivation of Drosophila Cdc2 kinase. Development. 1997;124:3555-3563.
42. Nasmyth K. Retinoblastoma protein. Another role rolls in. Nature. 1996; 382:28-29.
43. Jackson T, Allard MF, Sreenan CM, Doss LK, Bishop SP, Swain JL. Transgenic animals as a tool for studying the effect of the c-myc protooncogene on cardiac development. Mol Cell Biochem. 1991;104:15-19.
44. Jackson T, Allard MF, Sreenan CM, Doss LK, Bishop SP, Swain JL. The c-myc proto-oncogene regulates cardiac development in transgenic mice. Mol Cell Biol. 1990;10:3709-3716.
45. Rudolph B, Saffrich R, Zwicker J, Henglein B, Muller R, Ansorge W, Eilers M. Activation of cyclin-dependent kinases by Myc mediates induction of cyclin A, but not apoptosis. EMBO J. 1996;15:3065-3076.
46. Leone G, Degregori J, Sears R, Jakoi L, Nevins JR. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature. 1997;387:422-426.
47. WAF1/CIP1/SDI1. Oncogene. 1995;11:1409-1415.
48. KIP1 is abrogated by c-Myc. EMBO J. 1996;15:6595-6604.
49. Winston J, Dong F, Pledger WJ. Differential modulation of G1 cyclins and the Cdk inhibitor p27 kip1 by platelet-derived growth factor and plasma factors in density-arrested fibroblasts. J Biol Chem. 1996;271: 11253-11260.
50. Coats S, Flanagan WM, Nourse J, Roberts JM. Requirement of p27 kip1 for restriction point control of the fibroblast cell cycle. Science. 1996; 272:877-880.
51. 0 state) in fibroblasts. J Biol Chem. 1996;271:18337-18341.
52. Hengst L, Dulic V, Slingerland JM, Lees E, Reed SI. A cell cycle-regulated inhibitor of cyclin-dependent kinases. Proc Natl Acad Sci USA. 1994;91:5291-5295.
53. KIP1) of cyclin-dependent kinase 4 activation. Cell. 1994;79:487-496.
54. Polyak K, Kato J-Y, Solomon MJ, Sherr CJ, Massague J. Roberts JM, Koff A. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Devel. 1994;8:9-22.
55. Durand B, Gao F-B, Raff M. Accumulation of the cyclin-dependent kinase inhibitor p27/Kip1 and the timing of oligodendrocyte differentiation. EMBO J. 1997;16:306-317.
56. Bai SL, Campbell SE, Moore JA, Morales MC, Gerdes AM. Influence of age, growth, and sex on cardiac myocyte size and number in rats. Anat Rec. 1990;226:207-212.